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Abstract
Aims—We investigated the longitudinal association of depression, with and without cognitive 
dysfunction, with hemoglobin A1c (HbA1c), systolic blood pressure (SBP), and low-density 
lipoprotein (LDL) in a predominantly minority cohort.
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Methods—There were 613 participants. Presence of depression was defined by a score ≥ 7 on the 
Short-CARE depression scale. We tested participants for executive dysfunction using the Color 
Trails Test (CTT), part 2, and for memory dysfunction using the total recall task of the Selective 
Reminding Test (TR-SRT). We classified performance in these tests as abnormal based on 
standardized score cutoffs (<16th percentile and one standard deviation below the sample mean). 
Random effects models were used to compare repeated measures of the diabetes control measures 
between those with depression versus those without depression and ever versus never cognitively 
impaired.
Results—Baseline depression was present in 36% of participants. Over a median follow-up of 2 
years, depression was not related to worse HbA1c, SBP, or LDL. The presence of (1) abnormal 
performance on a test of executive function and depression (n = 57) or (2) abnormal performance 
on a test of verbal recall and depression (n = 43) was also not associated with clinically significant 
worse change in diabetes control.
Conclusions—Depression, with or without low performance in tests of executive function and 
memory, may not affect clinically significant measures of diabetes control in the elderly.
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1. Introduction
The prevalence of depression in communities of older adults with diabetes is approximately 
33% (Anderson, Freedland, Clouse, & Lustman, 2001). Diabetes self-management is 
complex and time-intensive, requiring patients to be meticulous and motivated. Individuals 
with depression are overwhelmed by feelings of sadness, negativity, loss of interest in 
activities, and fatigue, all of which combined may result in ineffective disease self-
management and medication non-adherence (Gonzalez et al., 2008). However, appropriate 
self-management of diabetes is important for the prevention of diabetes-related 
complications and other adverse outcomes (Haas et al., 2012). Poor self-management on the 
part of individuals with diabetes can lead to an increased incidence of related complications, 
such as, micro- and macro-vascular disease, and death (American Diabetes Association, 
2013).
Depression has been found to be highly prevalent in persons with diabetes, but few 
longitudinal studies have examined the impact of depression on diabetes control (Trief et al., 
2006). As people live longer with diabetes, depression has been shown to play a role in the 
adequacy of disease self-management and subsequent risk for diabetes-related 
complications. Moreover, depression is often accompanied by cognitive dysfunction 
(Richard et al., 2012), which may further affect the ability of a patient with diabetes to 
control their condition appropriately. Recent data from the ACCORD-MIND study showed 
that depression accelerated cognitive decline in type 2 diabetes (Sullivan et al., 2013). It is 
possible that cognitive decline accompanying depression could impact the ability of diabetes 
patients to adequately self-manage their disease. This problem may be more salient in 
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minority elders, who have a high prevalence of comorbid diabetes, cognitive dysfunction, 
and depression (Noble, Manly, Schupf, Tang, & Luchsinger, 2012).
We hypothesized that depression, with and without cognitive dysfunction, would be 
associated with worse control in the diabetes parameters usually followed by clinicians: 
glycemia, lipids, and blood pressure. We analyzed longitudinal data from a sample of 
minority elders with detailed longitudinal data on depression, cognitive performance, and 
parameters of diabetes control.
2. Subjects
The Informatics for Diabetes Education and Telemedicine (IDEA-Tel) project was initially 
designed to assess the feasibility and effectiveness of home-based telemedicine for 
management of diabetes in a sample of older adults residing in the state of New York (Shea 
et al., 2002). Participants were Medicare beneficiaries and resided in a federally designated 
medically underserved area. The exclusion criterion included the following: moderately or 
severely cognitively impaired; a severe visual, mobility or motor impairment; a severe 
comorbid condition; communication impairment; no electrical outlet for the telemedicine 
unit; or planned to reside in another location for more than 3 months. Adults >55 years of 
age (n =1,655), with type 2 diabetes, were randomized to receive the intervention (a home-
based interactive telemedicine unit used for televisits with a diabetes nurse educator, 
transmission of self-measured blood glucose and blood pressure data and access to the web 
in addition to usual care) or usual care alone. Changes in hemoglobin A1c (HbA1c), blood 
pressure and LDL cholesterol levels were the primary endpoints of IDEATel. Details of the 
study (inclusion/exclusion, randomization scheme, intervention and evaluation of primary 
study outcomes) have been previously described (Shea, 2007; Shea et al., 2002, 2009).
IDEATel had 2 study sites in New York State, Upstate, and Downstate (New York City). An 
ancillary cognition study was started in 2005 at the New York City (Columbia University) 
IDEATel site and was the source for the study sample reported in these analyses. IDEATel 
was carried out from 2000 to 2008 (Phase 1: 2000–2004, Phase 2: 2004–2008); 600 
participants in New York City (Columbia University site) were recruited in phase 1, and 150 
participated in phase 2. These 750 participants were all randomized to the telemedicine 
intervention or usual care. We recruited 613 of the 750 participants from phases 1 (n = 476) 
and 2 (n = 137) at the New York City site, for this cognition ancillary study between 2004 
and 2008 and participants were followed yearly until 2012. In addition to the baseline visit, 
538 (87.7%) participants had one follow-up visit, 437 (71.3%) had 2 follow-up visits, 350 
(57.1%) had 3 follow-up visits, 231 (37.4%) had 4 follow-up visits, and 90 (14.7%) had 5 
follow-up visits. Measures of memory and executive function were administered in this 
ancillary study in addition to the assessment of depression. The sole exclusion criterion for 
the ancillary study was non-willingness or inability to begin or complete the cognitive 
assessments. Columbia University's Institutional Review Board approved all protocols for 
this study. The baseline for the current analyses was the time of recruitment into the 
cognition ancillary study.
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3. Materials and methods
3.1. Assessment of depression
Presence of depression was measured using the SHORT-CARE Depression questionnaire 
(Gurland, Golden, Teresi, & Challop, 1984), a shortened version of the longer CARE 
depression scale (Gurland et al., 1977). The CARE questionnaire is based on the Geriatric 
Mental State Schedule (GMS) Depression scale (Copeland et al., 1976), but is shorter, easily 
administered by non-clinical personnel, and has been widely administered in ethnically 
diverse populations. The internal consistency reliability of the CARE depression measure in 
the development sample was 0.87; in the IDEATel sample the estimates ranged from 0.86 to 
0.89 across administrations. The interrater reliability estimate was 0.94 (Teresi, Golden, & 
Gurland, 1984). The measure evidenced high concurrent validity (0.75) with a clinical 
diagnosis of depression (Gurland et al., 1988). Depression was assessed in two ways. For the 
primary analysis, participants with a CARE score ≥ 7 at baseline were categorized as having 
depression; otherwise, they were categorized as not depressed. In a secondary analysis using 
all available follow-up data, participants with a CARE score ≥ 7 at any one visit were 
categorized as ever having depression; otherwise, they were categorized as never having 
depression. There is literature to suggest that a cutoff of 7 on the CARE questionnaire 
evidenced a high sensitivity and specificity for clinical depression in an elderly population 
(Mann, Graham, & Ashby, 1984).
3.2. Comorbid depression and low performance in cognitive tests
A secondary analysis was conducted examining the association of comorbid depression and 
low performance in cognitive tests, with diabetes control. Executive cognitive function can 
be broadly defined as the ability to plan, initiate and complete the execution of complex 
tasks (Royall et al., 2002) (e.g. planning and completing diabetes treatment). Memory can be 
defined as the ability to recall in general (e.g. remembering to take diabetes medications) 
(Small & Mayeux, 1999). Executive function was examined using the Color Trails Test 
(CTT), part 2 (D'Elia, Satz, Uchiyama, & White, 1996), and memory was assessed using the 
total recall (TR) task of the Selective Reminding Test (SRT) (Buschke & Fuld, 1974). In the 
CTT, part 2, the participant connects consecutively numbered dots that alternate between the 
colors pink and yellow. The main measure in this test is the time necessary to complete the 
task. In the SRT, the participant is asked to recall as many words as possible from a list of 
12 words in 6 trials. The total recall is the number of words remembered across the 6 trials. 
Low performance on the CTT and the TR-SRT were defined as a standardized score, <16th 
percentile or one standard deviation (SD) below the sample mean at baseline. This cutoff is 
typically used in clinical settings to categorize patients as “abnormal” on cognitive 
functioning (Binder, Iverson, & Brooks, 2009; Duara et al., 2011; Heaton, Grant, & 
Matthews, 1991; Heaton, Miller, Taylor, & Grant, 2004) as compared to the 1.5 SD cutoff 
used to classify mild cognitive impairment (MCI) (Petersen, 2004).
3.3. Outcomes
The primary outcomes were changes in measures of diabetes control, including, hemoglobin 
A1c (HbA1c), systolic blood pressure (SBP), and low-density lipoprotein (LDL) cholesterol. 
Both HbA1c and lipids were collected using 12-hr fasting blood samples. HbA1c was 
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analyzed by boronate affinity chromatography with Primus CLC 385 (Primus, Kansas City, 
MO). Lipid levels were analyzed using enzymatic colorimetric methods (Vitros; Johnson & 
Johnson, New Brunswick, NJ). The Friedewald equation was used to calculate LDL 
cholesterol (Friedewald, Levy, & Fredrickson, 1972). SBP was measured by averaging the 
second and third of three readings, taken 1 minute apart, using the Dinemap PRO 100 
automated device (Perloff et al., 1993).
3.4. Statistical analysis
Chi-square tests for categorical variables and the Kruskal–Wallis Test for continuous 
variables were used to test for significant differences in participant characteristics and 
diabetes control measures between participants with and without baseline depression.
Random effects models (Diggle, Heagerty, Liang, & Zeger, 2002), incorporating random 
effects for intercepts (i.e., individuals) and clustering within primary care provider (PCP), 
were used to examine the longitudinal relationship between baseline depression and changes 
in HbA1c, SBP, and LDL cholesterol. An interaction term in the random effects model was 
incorporated between depression and time to estimate the effect of depression on rates of 
change in measures of diabetes control across follow-up. Assessments of nonlinearity were 
performed by inclusion of quadratic (group × time2) and exponential terms (group × e-time) 
for time and evaluating goodness of fit statistics (i.e., Akaike Information Criterion (AIC) 
(Akaike, 1974) and Schwarz's Bayesian Information Criterion (BIC) (Schwarz, 1978)). 
Model fit did not improve significantly to warrant the use of these non-linear terms for time 
in the final models. In addition to age and education, demographic characteristics that were 
significantly different between exposure groups at baseline (sex and race/ethnicity) were 
adjusted for in the analyses. IDEATel randomization group assignment was also included in 
the final model to account for differences in the group due to the intervention. To account 
for possible confounding by diabetes severity, insulin, metformin, sulfonylurea or 
thiazolidinedione medication use was further adjusted in models of HbA1c outcomes. We 
also conducted sensitivity analyses examining (1) longitudinal assessment of depression 
(ever/never depressed across follow-up), (2) examining the outcomes in non-linear models, 
and (3) redefining cognitive dysfunction by a threshold of 1.5 SD rather than 1.0 SD.
A subsidiary analysis was performed to examine the association of comorbid depression and 
low performance in cognitive tests with changes in measures of diabetes control, compared 
to neither low performance nor depression. All analyses were performed using STATA 13.0 
(Stata Corp, College Station, TX).
4. Results
Among the 613 participants included in this analysis, the overall mean age of participants 
was 73 years, and 70% were female. Participants had an average of 7.5 years of formal 
education. Most participants were either Hispanic (82.5%) or Black (15.5%), with <1.0% of 
participants reporting White (non-Hispanic) race.
Amongst the analytic sample, 218 (36%) were classified with depression at baseline (Table 
1). Those with depression were more frequently women (p < 0.001) and Hispanic (p = 
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0.018). Mean (standard error) values of the diabetes control measures, accounting for 
clustering within PCP, are presented across each study visit and by baseline depression 
status in Table 2. No differences in baseline measures or rates of change in diabetes control 
measures were observed between participants with and without depression (Table 3). The 
inferences were unchanged after adjusting for low performance on the CTT and TR-SRT. In 
the subsidiary analysis, 9% (n = 57) of the total sample was classified as having both low 
performance in the CTT and depression at baseline (Table 4). Seven percent (n = 43) were 
classified as having both low performance in the TR-SRT and depression at baseline (Table 
5). No baseline differences were observed for HbA1c (Tables 4 and 5). Differences at 
baseline were observed in systolic blood pressure when comparing participants with 
executive dysfunction to those with neither depression nor executive dysfunction (β = 5.1, 
95% confidence interval: 0.3, 9.9). Differences at baseline were also observed in LDL 
cholesterol when comparing participants with only depression to those with neither 
depression nor memory dysfunction (β = −0.2, 95% confidence interval: −0.3, −0.01); 
however, these differences are likely not clinically significant. No differences in rates of 
change were observed for any of the diabetes control measures (Tables 4 and 5). In the 
secondary analyses, using a longitudinal assessment of depression (ever/never depressed 
across follow-up), the overall inference for the significance of the associations were 
unchanged (Tables 3, 4, and 5).
We conducted sensitivity analyses examining non-linear models and using different 
threshold levels for defining low performance in the CTT and TR-SRT, and the results were 
unchanged. We also examined effect modification by IDEATel randomization arm and time 
of study recruitment (phase 1 or 2) and found no evidence of effect modification.
5. Discussion
In this sample of older minority adults with type 2 diabetes, we found that the presence of 
depression was not independently associated with changes in the usual measures of diabetes 
control, glycemia, lipids, and blood pressure (American Diabetes Association, 2013). 
Depression with low performance in tests of executive function and memory was also not 
associated with changes in diabetes control compared to individuals with neither low 
cognitive performance nor depression.
The link between depression and poor glycemic control has been previously studied with 
some limitations. In a meta-analysis of 24 studies, researchers found that depression was 
significantly associated with hyperglycemia, a common indicator of diabetes control 
(Lustman et al., 2002). Cross-sectional studies have shown that depressive symptoms were 
significantly associated with poorer levels of total cholesterol, HbA1c, diastolic blood 
pressure and LDL after adjustment (Gary, Crum, Cooper-Patrick, Ford, & Brancati, 2000). 
However, a follow-up to this cross-sectional analysis with longitudinal data found no 
statistically significant associations between baseline depressive symptoms or change in 
depressive symptoms and diabetes control over a three-year period (Gary et al., 2005). A 
cross-sectional study of older adult African Americans also showed no association between 
depression and diabetes control (Nguyen et al., 2002). Our findings confirm those from 
another prospective study that showed no association between baseline depressive 
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symptoms or change in depressive symptoms and diabetes control over a three-year period 
(Gary et al., 2005). Compared to that study, most studies to date on depression and diabetes 
control have been cross-sectional and limited by small sample sizes (Gary et al., 2000; 
Lustman et al., 2002).
A previous analysis performed in the parent IDEATel cohort evaluated the effect of 
depressive symptoms on glycemic control and found no association cross-sectionally or 
longitudinally (Trief et al., 2006). Compared to this study, our study focused on the New 
York City sub-cohort that was predominantly composed of ethnic minorities and had 
cognitive data not available for the previous analysis. In addition, our analysis also focused 
on lipids and blood pressure as measures of diabetes control as compared to focusing solely 
on glycemia.
Several issues should be considered in the interpretation of the results. First, the parent 
IDEATel study was a randomized controlled trial (RCT), and the potential for selection bias 
in RCTs is high with the healthiest individuals most likely to enroll. Persons with moderate 
to severe cognitive impairment were excluded in the first phase of IDEATel, but they were 
not excluded from our recruitment during the second phase, when they may have developed 
cognitive impairment. These factors may limit the generalizability of our findings and the 
power to find a relationship between depression and diabetes control. Second, we tried to 
capture clinical depression using the CARE depression questionnaire. However, we did not 
have a clinical definition of depression nor information on the use of anti-depressant 
medication, and misclassification of depression could have led to our null findings. Third, 
we did not have a measure of diabetes process of care such as adherence, which have been 
reported to be affected by depression (Gonzalez et al., 2008). However, we believe that the 
examination of depression in relation to the most important clinical measures of diabetes 
management provides clinically significant information that most diabetes practitioners can 
relate to. Finally, this study population had a relatively well-controlled HbA1c at baseline 
and this may impact the ability to detect significant longitudinal changes in parameters of 
metabolic control relative to cognitive dysfunction and depressive symptoms.
In conclusion, this study showed that depression using the CARE questionnaire, which 
correlates with clinical depression, was not independently associated with poorer diabetes 
control in elderly patients with type 2 diabetes. Depression accompanied by low 
performance in cognitive tests also did not result in clinically significant poorer diabetes 
control compared to individuals with normal cognitive performance and no depression. The 
main clinical implication from our findings is that the presence of depression, found 
commonly in persons with diabetes, does not necessarily impact their diabetes control. 
However, depression is an important determinant of quality of life, and it should be screened 
for and treated appropriately among persons with diabetes. More studies are needed 
examining whether depression affects diabetes control in clinical cohorts.
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Table 1
Characteristics of study population (n = 613), by baseline depression status, at the baseline of IDEATel 
cognition ancillary study.
Characteristic Total sample N = 613 No depression CARE-Dep 
score < 7 n = 346
Depression CARE-Dep 
score ≥ 7 n = 218
p value
Age, years, mean (SD) 73.0 (6.5) 73.0 (6.6) 72.5 (6.3) 0.282
Female sex, n (%) 426 (69.5) 215 (62.1) 176 (80.7) <0.001
Education, years, mean (SD) 7.5 (4.1) 7.4 (4.1) 7.3 (4.1) 0.691
Race/Ethnicity, n(%) 0.018
    Hispanic 506 (82.5) 286 (82.7) 192 (88.1)
    African-American (non-Hispanic) 95 (15.5) 57 (16.5) 21 (9.6)
    White (non-Hispanic) 4 (0.007) 0 (0) 3 (0.01)
Insulin medication use, n (%) 164 (26.8) 99 (28.6) 65 (29.8) 0.759
Metformin medication use, n (%) 291 (47.5) 183 (52.9) 108 (49.5) 0.438
Sulfonylurea medication use, n (%) 228 (37.2) 152 (43.9) 76 (34.9) 0.033
Thiazolidinedione, n (%) 153 (25.0) 94 (27.2) 59 (27.1) 0.979
IDEATel intervention group 309 (50.4) 183 (52.9) 106 (48.6) 0.324
Hemoglobin A1c, % (mmol/mol), mean 7.4(57) 7.5 (58) 7.4(57) 0.460
Systolic blood pressure, mmHg, mean (SD) 140.2 (21.1) 140.4 (20.7) 139.9 (21.8) 0.614
Diastolic blood pressure, mmHg, mean (SD) 69.6 (10.9) 69.9 (10.7) 69.2 (11.1) 0.353
Total cholesterol, mmol/l, mean (SD) 4.4 (1.1) 4.4 (1.0) 4.4 (1.1) 0.916
HDL cholesterol, mmol/l, mean (SD) 1.3 (0.4) 1.2 (0.4) 1.3 (0.4) 0.140
LDL cholesterol, mmol/l, mean (SD) 2.5 (1.0) 2.5 (0.9) 2.5 (1.0) 0.650
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